Marshall Wace’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1M Sell
598,147
-324,499
-35% -$6.99M 0.01% 795
2026
Q1
$10.6M Sell
922,646
-112,499
-11% -$1.58M 0.01% 953
2025
Q4
$14.9M Sell
1,035,145
-102,694
-9% -$1.78M 0.01% 736
2025
Q3
$21.5M Buy
1,137,839
+1,108,638
+3,797% +$18.3M 0.02% 623
2025
Q2
$626K Buy
+29,201
New +$434K ﹤0.01% 2059
2025
Q1
– Sell
-44,400
Closed -$597K – 2968
2024
Q4
$597K Sell
44,400
-298,338
-87% -$4.8M ﹤0.01% 1972
2024
Q3
$7.27M Sell
342,738
-246,964
-42% -$4.45M 0.01% 872
2024
Q2
$9.33M Buy
+589,702
New +$10.8M 0.01% 760
2024
Q1
– Sell
-16,008
Closed -$146K – 2712
2023
Q4
$146K Buy
+16,008
New +$110K ﹤0.01% 2016
2021
Q2
– Sell
-14,448
Closed -$388K – 2963
2021
Q1
$388K Buy
+14,448
New +$452K ﹤0.01% 2034

Other funds holding OSCR

Marshall Wace's OSCR Position: Q2 2026 in Review

Marshall Wace reduced its Oscar Health (OSCR) stake by 35% in Q2 2026, selling an estimated $6.99M and leaving 598,147 shares worth $17.1M. The position accounts for 0.01% of the portfolio, ranked #795.

Marshall Wace first reported a position in OSCR in Q1 2021 and has held it in 10 quarters since. The position peaked at $21.5M in Q3 2025. 404 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Marshall Wace held 598,147 shares of Oscar Health worth $17.1M as of Q2 2026.
  • Marshall Wace sold 324,499 Oscar Health shares in Q2 2026, an estimated $6.99M.
  • Oscar Health made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #795 holding.
  • Marshall Wace first reported a position in Oscar Health in Q1 2021 and has held it in 10 quarters since.
  • Marshall Wace's Oscar Health position peaked at $21.5M in Q3 2025.
  • 404 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.